Showing results (111-120 of 756) with videos related to

Sort By:
Pageof 76
Stem Cells Translational Medicine|December 25, 2019
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administrationFederica Casiraghi, Norberto Perico, Eliana Gotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cellsFederica Casiraghi, Nadia Azzollini, Paola Cassis, et al.
Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.
The Lancet. Global Health|April 23, 2016
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional studyBogdan Ene-Iordache, Norberto Perico, Boris Bikbov, et al.
Journal of Chromatographic Science|July 24, 2008
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detectionDario Cattaneo, Franco Maggiolo, Diego Ripamonti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2021
Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Boris Bikbov, Maria José Soler, Vesna Pešić, et al.
Frontiers in Medicine|May 9, 2022
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Eclinicalmedicine|June 15, 2021
A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort studyFredy Suter, Elena Consolaro, Stefania Pedroni, et al.
Transplantation|November 9, 2007
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injuryPiero Ruggenenti, Norberto Perico, Eliana Gotti, et al.
Kidney International|February 10, 2012
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injuryPaola Cassis, Lorenzo Gallon, Ariela Benigni, et al.
Pageof 76